We are live on !
Find out more
Bleichroeder Portfolio holdings
AUM
$1.02B
Turnover
33.63%
1-Year Est. Return
33%
This Fund
S&P 500
This Quarter Est. Return
+40.48%
1 Year Est. Return
+33%
3 Year Est. Return
+222.49%
5 Year Est. Return
+219.92%
10 Year Est. Return
–
AUM
$565M
AUM Growth
+$183M
(+48%)
Cap. Flow
+$64.7M
Cap. Flow % of AUM
Cap. Flow %
11.44%
Top 10 Holdings %
Top 10 Hldgs %
66.34%
Holding
79
New
22
Increased
9
Reduced
6
Closed
5
Avg Time Held
0.3
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$55.2M |
| 2 |
Eos Energy Enterprises
EOSE
|
+$5.07M |
| 3 |
LiqTech
LIQT
|
+$4.94M |
| 4 |
Liberty Media Series A Liberty SiriusXM
LSXMA
|
+$3.45M |
| 5 |
Fate Therapeutics
FATE
|
+$2.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Welltower
WELL
|
+$6.7M |
| 2 |
Filana Therapeutics
FLNA
|
+$3.13M |
| 3 |
PayPal
PYPL
|
+$2.42M |
| 4 |
IHC
Independence Holding
IHC
|
+$1.12M |
| 5 |
RTN
Raytheon
RTN
|
+$566K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.61% |
| 2 | Industrials | 14.54% |
| 3 | Miscellaneous | 14.26% |
| 4 | Energy | 11.06% |
| 5 | Consumer Discretionary | 9.17% |
Similar funds
SW
Bleichroeder's Q2 2020 Portfolio in Review
As of Q2 2020, Bleichroeder held 79 positions worth $565M, up 48% from $383M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Bleichroeder deployed $64.7M of net new capital in Q2 2020, opening 22 new positions and adding to 9 existing holdings. Its largest new stake was Royalty Pharma: 1,115,980 shares worth $54.2M.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 20% a quarter earlier, followed by Industrials and Miscellaneous.
On the sell side, the largest reduction was Filana Therapeutics, an estimated $3.13M trimmed.
- Bleichroeder's largest Q2 2020 buy was Royalty Pharma: 1,115,980 shares worth $54.2M.
- Bleichroeder added most to LiqTech in Q2 2020, an estimated $4.94M increase.
- Bleichroeder's biggest Q2 2020 reduction was Filana Therapeutics, cutting an estimated $3.13M.
- Bleichroeder fully exited Welltower in Q2 2020, selling an estimated $6.7M.
- Bleichroeder's ten largest holdings make up 66% of its $565M portfolio in Q2 2020.
- Bleichroeder opened 22 new positions and closed 5 in Q2 2020.
- Bleichroeder's portfolio value rose 48% quarter-over-quarter to $565M.
Based on Bleichroeder's 13F filing for Q2 2020, filed 12 Aug 2020.